Gian M. Novaro, MD

Article Type

Article

Changed

Mon, 11/05/2018 - 09:53

Display Headline

Calcific aortic stenosis: Another face of atherosclerosis?

Author(s)

Gian M. Novaro, MD

Brian P. Griffin, MD

Article PDF

content_70_471.pdf

Author and Disclosure Information

Gian M. Novaro, MD
Department of Cardiovascular Medicine, The Cleveland Clinic, Weston, Florida

Brian P. Griffin, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Brian P. Griffin, MD, Section of Cardiovascular Imaging, F15, Department of Cardiology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44122; e-mail: griffib@ccf.org

Dr. Novaro has indicated that he has received grant or research support from Pfizer Inc.

Dr. Griffin has indicated that he is on the speakers' bureau of the Merck corporation and has received grant or research support from Pfizer Inc.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Issue

Cleveland Clinic Journal of Medicine - 70(5)

Publications

Cleveland Clinic Journal of Medicine

Topics

Cardiology

Vascular

Page Number

471-477

Read more about Calcific aortic stenosis: Another face of atherosclerosis?

Sections

Author(s)

Author(s)

Author and Disclosure Information

Gian M. Novaro, MD
Department of Cardiovascular Medicine, The Cleveland Clinic, Weston, Florida

Brian P. Griffin, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Brian P. Griffin, MD, Section of Cardiovascular Imaging, F15, Department of Cardiology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44122; e-mail: griffib@ccf.org

Dr. Novaro has indicated that he has received grant or research support from Pfizer Inc.

Dr. Griffin has indicated that he is on the speakers' bureau of the Merck corporation and has received grant or research support from Pfizer Inc.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

Gian M. Novaro, MD
Department of Cardiovascular Medicine, The Cleveland Clinic, Weston, Florida

Brian P. Griffin, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Brian P. Griffin, MD, Section of Cardiovascular Imaging, F15, Department of Cardiology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44122; e-mail: griffib@ccf.org

Dr. Novaro has indicated that he has received grant or research support from Pfizer Inc.

Dr. Griffin has indicated that he is on the speakers' bureau of the Merck corporation and has received grant or research support from Pfizer Inc.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF

content_70_471.pdf

Article PDF

content_70_471.pdf

Issue

Cleveland Clinic Journal of Medicine - 70(5)

Issue

Cleveland Clinic Journal of Medicine - 70(5)

Page Number